Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Comparison of CSF and MRI findings in patients with GBS and E coli meningitis^{^a}
Finding GBS (n = 57) E coli (n = 50) P Value^{^b}
CSF corrected WBC count (cells/μL) 3116 ± 5058 4770 ± 12684 1.00
CSF glucose (mg/dL) 35.2 ± 21.8 34.0 ± 24.6 1.00
CSF total protein (mg/dL) 517.8 ± 867.0 910.7 ± 1414.2 1.00
Leptomeningeal enhancement 49% 46% 1.00
Cerebritis 21% 7% .77
Ependymal enhancement 7% 28% .063
Abscess/granuloma 2% 2% 1.00
Subdural effusion 49% 26% .24
Hemorrhage 33% 46% 1.00
Extra-axial purulent material 37% 38% 1.00
Intraventricular purulent material 9% 22% .84
Sinus thrombosis 11% 4% 1.00
Hydrocephalus 0% 22% .0014
Infarct 40% 14% .038
↵a CSF values are listed as mean ± SD.
↵b P value is adjusted for multiple comparisons (n = 14).

Finding	GBS (n = 57)	E coli (n = 50)	P Value^{^b}
CSF corrected WBC count (cells/μL)	3116 ± 5058	4770 ± 12684	1.00
CSF glucose (mg/dL)	35.2 ± 21.8	34.0 ± 24.6	1.00
CSF total protein (mg/dL)	517.8 ± 867.0	910.7 ± 1414.2	1.00
Leptomeningeal enhancement	49%	46%	1.00
Cerebritis	21%	7%	.77
Ependymal enhancement	7%	28%	.063
Abscess/granuloma	2%	2%	1.00
Subdural effusion	49%	26%	.24
Hemorrhage	33%	46%	1.00
Extra-axial purulent material	37%	38%	1.00
Intraventricular purulent material	9%	22%	.84
Sinus thrombosis	11%	4%	1.00
Hydrocephalus	0%	22%	.0014
Infarct	40%	14%	.038